Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Arch Surg. 2004 Jun;139(6):648-51.

Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Author information

  • 1Department of Surgery, Columbia Presbyterian Comprehensive Breast Center, New York Presbyterian Hospital, NY, USA. kpr2@columbia.edu

Abstract

HYPOTHESIS:

The presence of nonsentinel lymph node (NSLN) metastasis after having a positive sentinel lymph node dissection finding is associated with tumor size and stage, the presence of lymphovascular invasion, micrometastasis, and extranodal extension.

DESIGN:

Retrospective case series.

SETTING:

University hospital.

PATIENTS:

Four hundred seven consecutive patients at a single institution who underwent sentinel lymph node dissection as part of breast conservation or mastectomy with biopsy-proved cancer.

INTERVENTION:

Completion axillary lymph node dissection and definitive therapy.

MAIN OUTCOME MEASURES:

Sentinel node metastasis, NSLN metastasis, tumor size and stage, lymphovacular invasion, micrometastasis, extronodal extension, histological tumor characteristics, and number of sentinel nodes removed.

RESULTS:

In a univariate analysis, size of the primary tumor and extranodal extension were associated with having positive NSLN findings. The presence of micrometastasis was associated with negative NSLN findings. When all factors were included in a logistic regression analysis, the significant predictor of NSLN metastasis was extranodal extension (P =.002). Lymphovascular invasion was not associated with positive NSLN findings (P =.11). The number of sentinel nodes removed also had no bearing on the status of the NSLNs (P =.37).

CONCLUSIONS:

Although primary tumor size and micrometastases correlate with the status of the NSLNs, extranodal extension is the most important independent predictor of NSLN metastasis. These findings may ultimately spare patients a full axillary lymph node dissection. However, pending results of larger clinical trials, full axillary lymph node dissection is still recommended for patients with sentinel lymph node metastases.

PMID:
15197092
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk